The Food and Drug Administration has permanently removed the in-person restriction on accessing abortion pills, allowing patients to receive the medication by mail after a telehealth consultation. Previously, pregnant people had to go to an on-site provider to take the prescription drug, though that requirement was lifted during the pandemic. The medication, mifepristone, was approved by the FDA in 2000 and has become an increasingly popular method of abortion. It is used in conjunction with the drug misoprostol. Reproductive rights advocates hailed the FDA decision at a time when the fate of Roe v. Wade hangs in the balance with a conservative-majority Supreme Court.